Clinical Trial Update: Efficacy of 200 IU OnabotulinumtoxinA in Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment

View source ↗

Summary

A completed clinical trial evaluating the efficacy of 200 IU of onabotulinumtoxinA for idiopathic overactive bladder in patients who did not respond to antichol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Botox (onabotulinumtoxinA) (onabotulinumtoxinA)

Snippet

Sponsor: Hisar Intercontinental Hospital | Conditions: Idiopathic Overactive Bladder Resistant to Anticholinergic Treatment | Status: COMPLETED